IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position
Galderma will share exciting phase III data on its novel, investigational, ready-to-use liquid botulinum toxin A, RelabotulinumtoxinA, further reinforcing its unprecedented efficacy and safety in...